13th Oct 2020 14:27
Feedback PLC - London-based medical imaging technology company - Pretax loss for the year ended May 31 widens to GBP1.4 million from GBP1.1 million a year before. Revenue down 20% to GBP449,983 from GBP563,092. Revenue down as the company shifts its focus away from radiomics tool TexRAD to its flagship clinical messaging product Bleepa. Chief Executive Tom Oakley said: "Our aim for the new year is to scale the product, at pace, in order to acquire as large a userbase as possible. Longer term, our vision is that Bleepa will become the platform that all frontline clinicians use to access information about their patients and confer with their peers to reach collective, informed treatment decisions."
Current stock price: 0.88 pence
Year-to-date change: down 11%
By Greg Roxburgh; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Feedback